Ratio Review: Analyzing Coherus Biosciences Inc (CHRS)’s Price-to-Cash and Price-to-Free Cash Flow

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

After finishing at $1.03 in the prior trading day, Coherus Biosciences Inc (NASDAQ: CHRS) closed at $0.95, down -7.56%. In other words, the price has decreased by -$7.56 from its previous closing price. On the day, 2.31 million shares were traded. CHRS stock price reached its highest trading level at $1.065 during the session, while it also had its lowest trading level at $0.9505.

Ratios:

Our goal is to gain a better understanding of CHRS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.21.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on August 16, 2024, Downgraded its rating to Neutral and sets its target price to $1.50 from $4 previously.

On November 17, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $11.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 110345528 and an Enterprise Value of 254262384. As of this moment, Coherus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41. Its current Enterprise Value per Revenue stands at 0.952 whereas that against EBITDA is -2.854.

Stock Price History:

The Beta on a monthly basis for CHRS is 0.91, which has changed by -0.586087 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, CHRS has reached a high of $2.61, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -16.38%, while the 200-Day Moving Average is calculated to be -24.77%.

Shares Statistics:

The stock has traded on average 2.00M shares per day over the past 3-months and 2470110 shares per day over the last 10 days, according to various share statistics. A total of 115.61M shares are outstanding, with a floating share count of 111.28M. Insiders hold about 3.97% of the company’s shares, while institutions hold 54.15% stake in the company. Shares short for CHRS as of 1740700800 were 30771823 with a Short Ratio of 15.37, compared to 1738281600 on 30895003. Therefore, it implies a Short% of Shares Outstanding of 30771823 and a Short% of Float of 30.969997999999997.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular